Patent application number | Description | Published |
20110311489 | OPTICALLY-BASED STIMULATION OF TARGET CELLS AND MODIFICATIONS THERETO - Stimulation of target cells using light, e.g., in vivo or in vitro, is implemented using a variety of methods and devices. One example involves a vector for delivering a light-activated molecule comprising a nucleic acid sequence that codes for light-activated molecule. The light-activated molecule includes a modification to a location near the all-trans retinal Schiff base, e.g., to extends the duration time of the open state. Other aspects and embodiments are directed to systems, methods, kits, compositions of matter and molecules for ion channels or pumps or for controlling currents in a cell (e.g., in in vivo and in vitro environments). | 12-22-2011 |
20130296406 | Optically-Based Stimulation of Target Cells and Modifications Thereto - Stimulation of target cells using light, e.g., in vivo or in vitro, is implemented using a variety of methods and devices. One example involves a vector for delivering a light-activated molecule comprising a nucleic acid sequence that codes for light-activated molecule. The light-activated molecule includes a modification to a location near the all-trans retinal Schiff base, e.g., to extends the duration time of the open state. Other aspects and embodiments are directed to systems, methods, kits, compositions of matter and molecules for ion channels or pumps or for controlling currents in a cell (e.g., in vivo or in vitro environments). | 11-07-2013 |
20140235826 | OPTICALLY-BASED STIMULATION OF TARGET CELLS AND MODIFICATIONS THERETO - Stimulation of target cells using light, e.g., in vivo or in vitro, is implemented using a variety of methods and devices. One example involves a vector for delivering a light-activated molecule comprising a nucleic acid sequence that codes for light-activated molecule. The light-activated molecule includes a modification to a location near the all-trans retinal Schiff base, e.g., to extends the duration time of the open state. Other aspects and embodiments are directed to systems, methods, kits, compositions of matter and molecules for ion channels or pumps or for controlling currents in a cell (e.g., in in vivo and in vitro environments). | 08-21-2014 |
Patent application number | Description | Published |
20090130020 | DIAGNOSTIC AGENTS FOR POSITRON EMISSION IMAGING USING F-18 RADIO-LABELED AMINO-ALCOHOLS - This invention relates to novel compounds F-18 radio-labeled amino-alcohols suitable for labeling or already labeled by | 05-21-2009 |
20100217011 | [F-18]-LABELED L-GLUTAMIC ACID, [F-18]-LABELED L-GLUTAMINE, DERIVATIVES THEREOF AND USE THEREOF AND PROCESSES FOR THEIR PREPARATION - The compounds and the synthesis of [F-18]-labeled L-glutamic acid, [F-18]-labeled L-glutamate, their derivatives as set forth in formula (I) and their uses are described. | 08-26-2010 |
20100290991 | NOVEL [F-18]-LABELLED L-GLUTAMIC ACID AND L-GLUTAMINE DERIVATIVES (I), THEIR USE AND PROCESSES FOR THEIR PREPARATION - What is described are the compounds and the synthesis of [F-18]-labelled L-glutamic acid, [F-18]-labelled L-glutamate, their derivatives of the formula (I) and their use. | 11-18-2010 |
20110064673 | New L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them - The present invention relates to fluorinated glutamic acid (glutamate) and glutamine derivatives wherein the fluorine atom is 19F. The glutamic acid (glutamate) and glutamine derivatives are compound(s) of general Formula I, which encompasses all possible diastereoisomers and/or enantiomere derivatives or mixtures thereof. | 03-17-2011 |
20110104057 | Novel [F-18]-labelled L-glutamic acid and L-glutamine derivatives (II), their use and processes for their preparation - What is described are the compounds and the synthesis of [F-18]-labelled L-glutamic acid, [F-18]-labelled L-glutamate, their derivatives of the formula (I) and their use. | 05-05-2011 |
20110112293 | Purification Strategy for Direct Nucleophilic Procedures - The present invention provides novel and advantageous processes for preparing and purifying chemical compounds such as pharmaceuticals. The processes comprise a nucleophilic substitution reaction with a moiety X wherein the leaving group L of a substrate S in the reaction is covalently attached to a purification moiety M. This concept offers a convenient and lime-saving way to purity the desired product S-X from non-reacted precursors S-L-M and by-products L-M. | 05-12-2011 |
20110137063 | COMPOUNDS AND PROCESSES FOR PRODUCTION OF RADIOPHARMACEUTICALS - The present invention relates to novel perfluorinated precursors for the production of F-18 labeled radiotracers for Positron Emission Tomography (PET) and processes for radiolabeling and purification using these precursors. The invention also comprises radiopharmaceutical kits using these precursors and processes. | 06-09-2011 |
20110165076 | NOVEL [F-18]- LABELLED L-GLUTAMIC ACID AND L-GLUTAMINE DERIVATIVES (I), USE THEREOF AND METHOD FOR THEIR PRODUCTION - What is described are the compounds and the synthesis of [F-18]-labelled L-glutamic acid, [F-18]-labelled L-glutamate, their derivatives of the formula (I) and their use. | 07-07-2011 |
20110184159 | PROCESS FOR PRODUCTION OF RADIOPHARMACEUTICALS - The present invention relates to novel processes for the production of F-18 labeled radiotracers for Positron Emission Tomography (PET). The invention also comprises radiopharmaceutical kits using these processes. | 07-28-2011 |
20120184749 | Usage of low to medium-pressure liquid chromatography for the purification of radiotracers - The invention relates to a process for the production of radiotracers. In particular, this invention relates the isolation of radiotracers with containers filled with a stationary phase. | 07-19-2012 |
20120238740 | NON-POLAR AND POLAR LEAVING GROUPS - The present invention provides novel and advantageous processes for preparing and purifying pharmaceuticals The processes comprise a nucleophilic reaction wherein a modified leaving group L | 09-20-2012 |
20130071327 | HOMOGLUTAMIC ACID DERIVATIVES - This invention relates to homoglutamic acid derivatives suitable for labeling or already labeled with | 03-21-2013 |
20130149243 | METHOD FOR PRODUCTION OF F-18 LABELED GLUTAMIC ACID DERIVATIVES - This invention relates to methods, which provide access to F-18 labeled glutamic acid derivatives. | 06-13-2013 |
20130172620 | METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS - This invention relates to methods, which provide access to [F-18]fluoropegylated (aryl/heteroaryl vinyl)-phenyl methyl amine derivatives. | 07-04-2013 |
20130209363 | METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS - This invention relates to methods, which provide access to [F-18]fluoropegylated (aryl/heteroaryl vinyl)-phenyl methyl amine derivatives. | 08-15-2013 |
20130217920 | METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS - This invention relates to methods, which provide access to [F-18]fluoropegylated (aryl/heteraryl vinyl)-phenyl methyl amine derivatives. | 08-22-2013 |
20140012032 | METHOD FOR PRODUCTION OF F-18 LABELED AMYLOID BETA LIGANDS - This invention relates to methods, which provide access to F-18 labeled stilbene derivatives. | 01-09-2014 |
20140243532 | NOVEL PRECURSORS OF GLUTAMATE DERIVATIVES - This invention relates to novel precursors suitable for | 08-28-2014 |
20140301948 | [F-18]-LABELED L-GLUTAMIC ACID, [F-18]-LABELED L-GLUTAMINE, DERIVATIVES THEREOF AND USE THEREOF AND PROCESSES FOR THEIR PREPARATION - The compounds and the synthesis of [F-18]-labeled L-glutamic acid, [F-18]-labeled L-glutamate, their derivatives as set forth in formula (I) and their uses are described. | 10-09-2014 |
20150011773 | RADIOLABELED AMINO ACIDS FOR DIAGNOSTIC IMAGING - This invention relates to novel compounds suitable for labeling by | 01-08-2015 |
Patent application number | Description | Published |
20080252637 | VIRTUAL REALITY-BASED TELECONFERENCING - A virtual reality environment is applied to teleconferencing such that the environment is used to enter into a teleconference. | 10-16-2008 |
20080253547 | AUDIO CONTROL FOR TELECONFERENCING - A virtual representation includes objects that represent participants (i.e., users) in a teleconference. Volume of sound data in the teleconference is controlled according to how the users change location and relative orientation of their objects in the virtual representation. | 10-16-2008 |
20080256452 | CONTROL OF AN OBJECT IN A VIRTUAL REPRESENTATION BY AN AUDIO-ONLY DEVICE - Control of objects in a virtual representation includes receiving signals from audio-only devices, and controlling states of the objects in response to the signals. | 10-16-2008 |
20080294721 | ARCHITECTURE FOR TELECONFERENCING WITH VIRTUAL REPRESENTATION - A communications system includes a teleconferencing system for hosting teleconferences, and a server system for providing a virtual representation for the teleconferencing system. The virtual representation includes objects whose states can be commanded to transition gradually. The server system provides clients to client devices, and each client causes its client device to display the virtual representation. Each client device is capable of generating a command for gradually transitioning an object to a new state in the virtual representation and sending the command to the server system. The server system commands the clients to transition an object to its new state by a specified time. | 11-27-2008 |
20090106670 | SYSTEMS AND METHODS FOR PROVIDING SERVICES IN A VIRTUAL ENVIRONMENT - A network-accessible virtual environment includes objects that represent users of a service. The users are allowed to control their representative objects in the virtual environment to interact with other users represented in the virtual environment and also to become voice-enabled. Those users who are voice-enabled can speak with other voice-enabled users via phones. | 04-23-2009 |
Patent application number | Description | Published |
20090165519 | Peening Device - The invention relates to a peening device for peening a component with a part to be peened and a part not to be peened. The peening device comprises a chamber with at least one opening located therein, wherein the opening is dimensioned in such a manner that the part not to be peened of the component can be guided there through, and a fixture for retaining the component which features a section which entirely covers the opening of the chamber when the part not to be peened is at least partially guided into said opening, and said section completely encloses the part not to be peened of the component between the adjacent region of the part to be peened of the component and the opening. | 07-02-2009 |
20100086757 | Method for coating a component - A method is provided for coating a component with a multilayer ceramic coating in which the individual layers of the ceramic coating are applied covering one another on the component, and in which ceramic particles are supplied to a coating burner, melted partly or completely by the coating burner, and deposited on the component. The ceramic particles have a particle size, which increases from layer to layer, and are supplied to the coating burner. Furthermore, a multilayer ceramic coating and a component which has with a multilayer ceramic coating are provided. | 04-08-2010 |
20110135947 | Masking Material, Masking Layer, Process for Masking a Substrate and Process for Coating a Substrate - A two-layer system made of ceramic powder and metallic powder is provided. The ceramic powder may include zirconium oxide, aluminum oxide, titanium oxide, a perovskite, a spindle, a pyrochore and/or boron nitride and mixtures thereof. The metallic powder may include nickel, aluminum, cobalt and/or chromium, and mixtures or alloys thereof. A masking layer and a process for masking a substrate are also provided. | 06-09-2011 |